Genetically encoded nanosensor 3.2 mM High throughput glucose assay Immobilization on 96-well microtiter plates FRET a b s t r a c t Glucose monitoring in vivo is a crucial issue for gaining new understanding of diabetes. Glucose binding protein (GBP) fused to two fluorescent indicator proteins (FLIP) was used in the present study such as FLIP-glu-3.2 mM. Recombinant Escherichia coli whole-cells containing genetically encoded nanosensors as well as cell-free extracts were immobilized either on inner epidermis of onion bulb scale or on 96-well microtiter plates in the presence of glutaraldehyde. Glucose monitoring was carried out by Förster Resonance Energy Transfer (FRET) analysis due the cyano and yellow fluorescent proteins (ECFP and EYFP) immobilized in both these supports.
Introduction
Glucose is an important physiological analyte involved in major catabolic pathways such as glycolysis and oxidative phosphorylation. Therefore, the maintenance and regulation of glucose concentration are critical issues for proper physiological function [1] . Continuous blood glucose monitoring is a key issue of modern diabetes treatment, particularly in type 1 diabetes as well as insulin-dependent type 2 diabetes [2] . The search for the ideal glucose sensor has been a long-time goal of many researchers and as a result, many glucose sensors have been developed in the last few decades [3] . Although many glucose sensing systems have found in vivo applications, the need for a reliable, specific, sensitive and stable glucose sensor is highly required [4] . There are many parameters that affect the development of an optimized glucose sensor such as selectivity, linear range, biocompatibility, response time, reproducibility and reversibility of signal [5] . Moreover, these enzyme electrodes are based on a chemical conversion [6] with a consumption of glucose and O 2 and production of hydrogen peroxide and d-gluconic acid in vivo. A promising alternative to electrochemistry has been investigated by several research groups which is fluorescence-based glucose sensing [2, 7, 8] . This is a powerful method suitable for fast, sensitive, reagentless, and non-invasive detection of neutral analytes such as glucose [7] [8] [9] .
Glucose binding protein (GBP) has been used for glucose sensing by several research workers [8] . Mature genetically engineered GBP was fused to enhanced yellow fluorescent protein (EYFP) and enhanced cyano fluorescent protein (ECFP) containing histidine affinity tag for glucose sensing in plants [10] . The levels of glucose were quantified by Fluorescence Resonance Energy Transfer (FRET) measurements which allow the determination of ratio of emission intensity of EYFP/ECFP [11] . Although several research workers have used these genetically encoded nanosensors for glucose assay, they were used in a soluble and purified form [10] . In the last decade, there is an increasing interest on whole-cell biosensors [12] [13] [14] since microbial cells can be genetically manipulated to be used as whole-cell biosensors for a wide range of biomolecules in order to optimize the sensitivity, selectivity and robustness. On the other hand, the nature of immobilization supports used and the high throughput assay method are also critical issues for a good glucose biosensor.
Therefore, the present work involves the immobilization of recombinant whole-cells and cell-free extract containing genetically encoded biosensors on onion membranes and 96-well microtiter plates. These nanosensors will be used for glucose assay either in free or immobilized forms.
Materials and methods

Chemicals
Glutaraldehyde, Coomassie Blue dye, 96-well tissue culture microtiter plates (polystyrene), imidazole, ampicillin, glucose oxidase and peroxidase were purchased from Sigma-Aldrich (St. Louis, MO, USA). LB medium components were supplied by HiMedia Laboratories (Mumbai, India). Onions were obtained from a local supermarket. All other chemicals used were of analytical grade.
Recombinant plasmids containing genetically encoded glucose nanosensors
Recombinant plasmids containing FLIP-glu-3.2 mM was obtained from Addgene, USA. This nanosensor had a dissociation constant (Kd) of 3.2 mM for glucose [15] .
Methods
Maintenance and growth conditions of recombinant Escherichia coli strains
Recombinant plasmid containing FLIP-glu-3.2 mM was used to transform E. coli strains and the recombinant strains were grown in solid Luria Bertani (LB) medium containing 100 g/ml ampicillin of culture medium at 37 • C for 24 h in order to obtain single colonies.
Production of fluorescent indicator protein (FLIP) nanosensors
The production and extraction of FLIP nanosensors from recombinant E. coli was carried out as described previously with major modifications [10] . Briefly, single colonies of recombinant E. coli containing FLIP-glu-3.2 mM were grown in LB medium containing 100 g/ml ampicillin in the dark at 21 • C, 150 rpm for 2-3 days. The cells were harvested by centrifugation at 10,000 rpm for 5 min at 4 • C, washed with saline and centrifuged again at same speed. The supernatant was discarded and the pellet was stored at −20 • C.
The cells were thawed, resuspended in 2 volumes of 20 mM Tris-HCl buffer pH 8.0 containing 1 mM benzamidine and sonicated at 4 • C for 30 s, for three times and centrifuged at 19,000 rpm for 1 h. The supernatant was recovered and used as the cell-free extract which was a source of FLIP nanosensors.
Immobilization of FLIP glucose nanosensors
As far as immobilization on inner epidermis of onion bulb scale is concerned, it was carried out as published previously with major modifications [16] . Preliminary experiments were carried out in order to optimize several parameters such as the amount of wholecells, cell-free extract, concentration of glutaraldehyde and drying time on the support. Briefly, circular membrane of the epidermis were cut (5-10 mm diameter) and suitable aliquots of recombinant E. coli cells and cell-free extracts in 20 mM Tris-HCl buffer pH 8.0 containing 1 mM benzamidine were transferred to these membranes, dried for 1 h at room temperature. A suitable amount of glutaraldehyde (8 l) was added to the membrane and incubated at room temperature for 45 min. Subsequently, membranes were washed several times with 20 mM Tris-HCl buffer pH 8.0 containing 1 mM benzamidine and stored in the same buffer at 4 • C. As far as fluorescence measurements are concerned, these membranes were transferred to a 96-well microtiter plate containing 200 l of 50 mM phosphate buffer pH 7.0 containing 1 mM benzamidine per well and readings were carried out in a microtiter plate reader. These membranes were stored at 4 • C in the same buffer system and they were re-used several times. Regarding the immobilization of whole-cells and cell-free extracts on tissue culture 96-well microtiter plates, suitable aliquots of these biosensors were transferred to these plates and dried overnight at room temperature. Subsequently, appropriate concentration of glutaraldehyde (20 l) was added to the wells and the same procedure was followed as described above. These microtiter plates were stored at 4 • C in the same buffer system and they were re-used several times.
Spectra measurement of free and immobilized glucose nanosensors
Fluorescent measurements were carried out either on spectrofluorimeter (JASCO FP-8300 in a quartz cuvette) or on Fluorstar Optima microtiter plate reader (excitation: 433 nm and emission: 485 nm and 528 nm) in 100 l of 50 mM phosphate buffer pH 7.0 containing 1 mM benzamidine per well as described previously with major modifications [10] . Briefly, measurements were carried out in the Spectrofluorimeter (Jasco) and spectra were obtained in 50 mM phosphate buffer pH 7.0 containing 1 mM benzamidine (100 l) as the background. Increasing concentrations of glucose (0.01, 0.1, 1.0 e 10 mM) in the same buffer system were added to the soluble forms of cell-free extract or whole-cells (100 l) containing the glucose nanosensor. The same procedure was carried out for the immobilized glucose nanosensor on circular membrane and on 96-well microtiter plates and spectra were measured either in the wavelength range of 400-600 nm (Spectrofluorimeter) or in microtiter plate reader (excitation: 433 nm and emission: 485 nm and 528 nm).
Glucose assay
FRET analysis was calculated as the ratio of the fluorescence intensity at 528 nm divided by the fluorescence intensity at 485 nm. Spectra measurements were carried out of the free form of both nanosensors in the presence and absence of glucose as the ligand. The presence of glucose alters the fluorescence intensity of the yellow (530 nm) and cyano (485 nm) of FLIP nanosensors. The spectra measurements were carried out by using free and immobilized forms of both nanosensors in the presence and absence of glucose as the ligand. A calibration curve for glucose was carried out by using FRET measurements in the linear range of 0-24 mM glucose as described in Section 2.2.4. For comparative purposes, glucose was assayed in several samples of human sera by using the present FRET method and a conventional colorimetric assay method based on glucose oxidase and peroxidase [6] .
Stability of immobilized FLIP glucose nanosensors
Immobilized FLIP glucose nanosensors (microtiter plates and onion membranes) were used to investigate their storage and operational stabilities. Therefore, fluorescence measurements were carried out in the presence and absence of glucose in order to determine their stability as a function of time by measurements of glucose assay in microtiter plate reader. These nanosensors were stored in 50 mM phosphate buffer pH 7.0 containing 1 mM benzamidine at 4 • C.
Selectivity of genetically encoded nanosensors
The selectivity of these nanosensors was investigated by using several carbohydrates as ligands in order to study their effect on the ratio of EYFP/ECFP compared with the glucose by using different ligand concentrations.
Protein assay
Protein concentration of cell-free extracts were carried out by coomassie blue dye binding method by using BSA as the protein standard as mentioned previously with minor modifications [17] .
Results and discussion
Production of genetically encoded glucose nanosensors
Genetically-encoded FRET nanosensors have been developed for measuring the dynamic changes in concentration of several metabolites of biological interest [10] . The present FRET sensor contains GBP which was fused to a fluorescent pair with overlapping emission and excitation spectra (i.e. ECFP and EYFP). The binding of the metabolite of interest induces a conformational change that affects the relative distance and/or orientation between the two fluorescent proteins which can cause either an increase or a decrease in FRET efficiency. These FLIP nanosensors were detected in LB culture medium by measurement of fluorescence spectrum between 400 and 600 nm (Fig. 1A) since there are two fluorescence peaks at about 485 and 530 nm. Moreover, the fluorescence spectrum of cell-free extract of FLIP-glu-3.2 mM nanosensor was obtained in the presence and absence of glucose which revealed a decrease in fluorescence of EYFP and an increase of ECFP as shown in Fig. 1B. 
Immobilization of FLIP glucose nanosensors
The 96-well tissue culture microtiter plates and onion membranes were selected as immobilization supports since they exhibited the best results as far as recovery and retention of biological activity are concerned. The cell wall of inner epidermis cells contains several biological macromolecules such as polygalacturonic acid, hemicelluloses, proteins and lignin [18] . Therefore, onion membranes exhibit a biocompatible microenvironment and stable support for immobilization of whole-cells and cell-free extract.
The immobilization of these nanosensors on both these supports resulted in recovery of fluorescence in the range of 50-90% which was represented as the percentage of the ratio EYFP/ECFP compared with the free form of the nanosensor (Figs. 2 and 3) .
As far as glutaraldehyde is concerned, several concentrations were tested and it was found that lower concentrations of glutaraldehyde exhibited higher recovery of fluorescence of either the immobilized whole-cells or cell-free extract on both supports (Fig. 2) . The effect of the amount of whole-cells and cell-free extract on fluorescence recovery at a constant concentration of glutaraldehyde (i.e. 2%, v/v) was also investigated which revealed that lower amounts of nanosensor exhibited higher recovery of fluorescence of either the immobilized whole-cells or cell-free extract on both supports (Fig. 3) . Therefore, these data indicate that the rate-limiting step seems to be the low capacity of the onion membranes as well as the wells of the microtiter plates [16, 18] .
Glucose assay
Glucose assay was carried out by using free and immobilized genetically encoded nanosensor in the range of 0-100 mM as shown in Fig. 4 . As expected, the ratio of EYFP/ECFP decreased as the glucose concentration increased for the free form of the nanosensor for whole-cells and cell-free extract (Fig. 4A) . The cellfree extract presented higher FRET values than whole-cells because it has a higher amount of soluble protein compared with the whole-cells (Fig. 4A) . Moreover, the nanosensor in cell-free extract and whole-cells may be in different conformations which has been also mentioned by other research workers in the literature [12, 19] . However, as far as the immobilized cell-free extract and wholecells on onion membrane are concerned, the data revealed an increase in the ratio as a function of glucose concentration which suggest that there is an increase in FRET efficiency (Fig. 4B) . Similar results were also obtained with immobilized nanosensors in 96-well microtiter plates (data not shown). This result was unexpected but it may be explained by the fact that the covalently immobilized nanosensor is bound to the immobilization support in such a way that both fluorescent proteins (i.e. EYFP and ECFP) may be located further apart. Subsequently, the binding of glucose to GBP induces a conformational change which may apparently bring closer both these two fluorescent proteins and therefore there is an increase in FRET efficiency. Several research workers have reported that FRET is apparently a very complex process when free and immobilized whole-cells or cell-free extracts are involved [19] [20] [21] [22] . Regarding the differences in FRET efficiencies between the free and immobilized nanosensors, there are a number of factors affecting immobilized and soluble proteins such as restricted mobility on immobilization, chemical modification due to the immobilization method used, nature of the microenvironment and diffusion limitation [20] . There are several reports in the literature that have mentioned different fluorescent behavior in the FRET pair between free and immobilized nanosensors due to some factors mentioned above. Apparently, this difference may be due to the reduced flexibility of the linker domain between the fluorescent proteins because of the attachment to solid surface. This issue emphasizes the importance to retain flexibility of both the fusion proteins in devising FRET pairs for immobilization to solid surfaces [19, 21] . In general, FRET theory assumes that in a FRET couple only a single donor and a single acceptor are present with very weak coupling. However, in cell-free extracts or wholecells, it is generally unknown if a single or multiple acceptors are present which markedly complicates the calculation of FRET efficiency. Moreover, other problems must be evaluated and controlled such as cross-talk between FRET partners, effect of pH on their microenvironment and difference in stoichiometric ratios of donor and acceptor biomolecules [23, 24] . However, this immobilized nanosensor was successfully used to assay glucose in real samples of human sera (Table 1) . A calibration curve for glucose assay has been presented in Fig. 4C by using immobilized cell-free extract on onion membrane. A limit of detection (LOD) of 0.11 mM glucose was obtained according to IUPAC and ICH [25] . However, upconversion luminescence nanosensors have been used to assay for glucose with a LOD of 64 nM which is much lower than the value presented in this work [26] . A comparative study was carried out by using a well-established conventional colorimetric assay for glucose with glucose oxidase and peroxidase which revealed that the results are slightly lower with the FRET method compared the colorimetric method (Table 1) . These results may be explained by the fact that some interfering substances in human serum may affect the FRET method. However, this difference is not significant since very similar results were obtained for both methods (Table 1) . Similar results were obtained by using immobilized whole-cells and cell-free extract on 96-well microtiter plates (data not shown).
Stability of immobilized FLIP glucose nanosensors
The data presented in Fig. 5 revealed that the immobilized nanosensors exhibited a very high storage stability at 4 • C of over 6 and 7 months for onion membrane and tissue culture microtiter plate, respectively ( Fig. 5A and B) . On the other hand, the operational stability of these immobilized nanosensors was also investigated by assaying for glucose as a function of the number of cycles which revealed that they could be used at least 20 cycles without any significant loss of biological activity as far as FRET signal is concerned (Fig. 5C ). 6 . Selectivity of FLIP-glu-3.2 mM nanosensor. Different concentrations of several sugars were used to investigate their effect on the ratio by using free whole-cells.
Selectivity of genetically encoded nanosensors
The selectivity of FLIP-glu-3.2 mM nanosensor was investigated by using several mono and disaccharides on the ratio which revealed that galactose exhibited a very small cross-reactivity with the nanosensor compared with the glucose (Fig. 6 ). This result is in agreement with published reports on the selectivity of these genetically encoded nanosensors [10] .
Conclusions
Recombinant E. coli whole-cells and cell-free extract containing genetically encoded nanosensors were immobilized on onion membrane and tissue culture microtiter plates with high recovery of biological activity. This method was used to quantify glucose in real human sera samples and the results are in agreement with a well-established colorimetric assay method. This assay method is based on 96-well microtiter plate which can be used as a high throughput assay method for glucose since it is cheap, rapid and many samples can be assayed on a single platform. The storage and operational stability of these nanosensors are high and therefore they can be re-used several times. To author knowledge, this is the first report on the use of immobilized whole-cells and cell-free extract containing genetically encoded nanosensors for glucose assay by using these two novel supports.
